COVID-19 vaccine (Courtesy Baylor Scott & White Health).


COVID-19 Bulletin (09/27/21)

FDA and CDC approve Pfizer booster for high risk populations. Vaccine rate slowing in Texas.

Dallas County Judge Clay Jenkins reported 1,147 new cases and 22 deaths on Friday.

FDA and the CDC approved Pfizer booster for high-risk populations, NPR reports. High-risk populations include individuals 65 years and older, individuals 18-64 at high risk of severe COVID-19, and individuals 18-64 whose job or institutional exposure puts them at high risk of COVID-19. Learn more about the FDA authorization here.F

North Texas doctor says clinical trials on new COVID-19 treatments show positive results, WFAA reports. Dr. Haresh Boghara with Epic Medical Research Pfizer is studying potential COVID-19 treatment drugs, including the Pfizer pill. Clinical trials are seeing the benefits of combining the Pfizer pill with Ritonavir, an existing antiviral drug.

Texas’ rate of COVID-19 shots administered has slowed, Texas Tribune reports. 83 percent of Texas are currently eligible for a vaccine and 50 percent of Texans are fully vaccinated. Texas Tribune reports the lagging of vaccination rates as related to mistrust in the government and healthcare system by demographics.


Keep me up to date on the latest happenings and all that D Magazine has to offer.